The PET-CT Academy experts will provide a comprehensive overview of PET-CT imaging of neuroendocrine tumours while presenting various case studies throughout this hour webinar recording.
Agenda
Appropriate and effective application of SSTR PET and FDG tracers, including the grade of NET and identifying false positives - presented by Dr Thomas Westwood.
Patient preparation and imaging for 68Ga DOTATOC PET-CT: Current medication, managing symptomatic patients and the timing of SSA - does the 4 weeks interval really matter? - presented by Andy Connelly
Interesting Cases with a particular focus on SPECT CT vs PET CT - the detection of primary and burden of disease and FDG vs SSTR - presented by Dr Ami Chander
Summary, Discussion and Q&A - Chaired by Dr Prakash Manoharan with all speakers in attendance.
Learning Outcomes
A better understanding of the role of the different PET-CT tracers based on the underlying pathophysiology of NET and how to avoid pitfalls.
Dealing with the complex needs of the NET patients undergoing diagnostic imaging investigations.
Limitations of SSTR, SPECT and CT technology in the assessment of NET patients.
Interesting cases to highlight and consolidate the learning outcomes.
Intended Audience
All PET-CT clinical Radiologists, Technologists and Radiographers, plus any other clinical staff who might have an interest in PET CT imaging of Neuroendocrine Tumours.
Disclaimer
This webinar does not constitute the practical training required to undertake these procedures.
This webinar took place and was recorded on 11th May 2022.
